ArticleMultiple sclerosis journal - experimental, translational and clinical
Clinical relevance and predictors of anti-natalizumab antibodies in multiple sclerosis: A real-world retrospective cohort study.
Michael Levy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.